These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29730946)

  • 61. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients.
    Ro Y; Eun CS; Kim HS; Kim JY; Byun YJ; Yoo KS; Han DS
    Gut Liver; 2016 Jul; 10(4):581-6. PubMed ID: 27021503
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proton pump inhibitors: Clostridium difficile infections.
    Prescrire Int; 2013 Oct; 22(142):239-40. PubMed ID: 24298587
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
    Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Continued high use of PPIs despite C. difficile risk.
    Brown C
    CMAJ; 2014 Dec; 186(18):1350. PubMed ID: 25384647
    [No Abstract]   [Full Text] [Related]  

  • 65. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.
    Leonard AD; Ho KM; Flexman J
    Intern Med J; 2012 May; 42(5):591-4. PubMed ID: 22616966
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Do PPIs have long-term side effects? Nexium and the other proton-pump inhibitors are great at reducing stomach acid, but that might have some unintended consequences.
    Harv Health Lett; 2009 Jan; 34(3):4-5. PubMed ID: 19172761
    [No Abstract]   [Full Text] [Related]  

  • 67. Clostridium difficile.
    Baierlein SA; Wistop A
    N Engl J Med; 2009 Feb; 360(6):636-7; author reply 637-8. PubMed ID: 19202581
    [No Abstract]   [Full Text] [Related]  

  • 68. Proton pump inhibitor therapy and osteoporosis.
    Yang YX
    Curr Drug Saf; 2008 Sep; 3(3):204-9. PubMed ID: 18691003
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.
    Johnson DA; Katz PO; Armstrong D; Cohen H; Delaney BC; Howden CW; Katelaris P; Tutuian RI; Castell DO
    Drugs; 2017 Apr; 77(5):547-561. PubMed ID: 28233274
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS.
    Chinzon D; Domingues G; Tosetto N; Perrotti M
    Arq Gastroenterol; 2022; 59(2):219-225. PubMed ID: 35830032
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism.
    Swaminathan K
    Indian J Pharmacol; 2015; 47(3):330-1. PubMed ID: 26069375
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
    Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
    van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
    Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Staying healthy while using PPIs. Be mindful of risks for fracture, low B12, and a spike in stomach acid.
    Harv Health Lett; 2015 Feb; 40(4):7. PubMed ID: 26223055
    [No Abstract]   [Full Text] [Related]  

  • 76. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.
    Freedberg DE; Lamousé-Smith ES; Lightdale JR; Jin Z; Yang YX; Abrams JA
    Clin Infect Dis; 2015 Sep; 61(6):912-7. PubMed ID: 26060292
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proton pump inhibitors: bacterial pneumonia.
    Prescrire Int; 2012 Sep; 21(130):210-2. PubMed ID: 23016253
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Magnesium deficiency and proton pump inhibitors].
    Bruserud Ø; Hansen BA
    Tidsskr Nor Laegeforen; 2016 Sep; 136(16):1336. PubMed ID: 27637049
    [No Abstract]   [Full Text] [Related]  

  • 79. A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long-Term Safety.
    Dubcenco E; Beers-Block PM; Kim LP; Schotland P; Levine JG; McCloskey CA; Bashaw ED
    Clin Transl Sci; 2017 Sep; 10(5):387-394. PubMed ID: 28618191
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hypomagnesemia and proton-pump inhibitors.
    Famularo G; Gasbarrone L; Minisola G
    Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.